Advertisements



New Erectile Dysfunction Treatment Likely to Face Stiff Competition If Approved

The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes......»»

Category: blogSource: 247wallstNov 8th, 2018

AstraZeneca says Lynparza approved in Japan for treatment of advanced cancers

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 28th, 2020

Gilead Sciences Gains Remdesivir Approval in Japan

Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment......»»

Category: blogSource: 247wallstMay 8th, 2020

Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK"d its emergency use

Associated Press A promising coronavirus treatment called remdesivir was approved last week for emergency use in the US. Now, some hospitals are having a hard time getting the drug for their patients. The US government is deciding which hospitals will .....»»

Category: topSource: businessinsiderMay 6th, 2020

EU clears 7 billion euros in state aid for Air France

The European Union's competition watchdog on Monday approved French state aid worth 7 billion euros ($7.66 billion) for Air France , saying the support would provide cash to soften the economic shock of the coronavirus pandemic......»»

Category: topSource: reutersMay 4th, 2020

Judge orders Uber to face suit alleging it stifled competition, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 1st, 2020

Uber must face lawsuit claiming it stifled competition, drove out rival Sidecar

Uber Technologies Inc was ordered by a U.S. judge on Friday to face a lawsuit claiming its illegal predatory pricing and other anticompetitive practices stifled competition, and drove rival Sidecar Technologies Inc out of business......»»

Category: topSource: reutersMay 1st, 2020

Why This Alzheimer’s Study Could Be Huge

As there is currently no FDA-approved treatment for Alzheimer’s agitation, any progress here could be lucrative. Axsome Therapeutics has announced a big step forward in its midstage Alzheimer’s study.....»»

Category: blogSource: 247wallstApr 27th, 2020

Takeaway.com"s $7.6B takeover of food delivery rival Just Eat approved by UK regulator

Dutch food delivery firm Takeaway.com's £6.2 billion takeover of British rival Just Eat has been cleared by the U.K. competition regulator......»»

Category: topSource: moneycentralApr 23rd, 2020

Amazon to roll out mask, temperature checks next week

In response to stiff criticism, Amazon.com plans to roll out temperature checks and face masks for staff at all its U.S. and European warehouses and Whole Foods locations next week, Reuters learned exclusively. Conway G. Gittens has the details......»»

Category: videoSource: reutersApr 2nd, 2020

COVID-19 "Miracle Drug" Goes On FDA Shortage List After Study Confirms Efficacy

COVID-19 'Miracle Drug' Goes On FDA Shortage List After Study Confirms Efficacy Days after the FDA approved the use of hydrochloroquine as a treatment for COVID-19, weekly presc.....»»

Category: blogSource: zerohedgeApr 1st, 2020

Trump Tells America "Get Ready For A Painful 2 Weeks" As Task Force Goes "All-In" On Mitigation

Trump Tells America "Get Ready For A Painful 2 Weeks" As Task Force Goes 'All-In' On Mitigation Update (18000ET): There's been some pretty stiff competition, but Tuesday night's press conference was an entertaining one. For the second nig.....»»

Category: blogSource: zerohedgeMar 31st, 2020

Why Bristol-Myers Squibb"s Stock is Trading Higher Today

Bristol-Myers Squibb Company (NYSE: BMY) shares are trading higher after the company announced the FDA has approved ZEPOSIA, its new oral treatment for relapsing forms of multiple sclerosis. read more.....»»

Category: blogSource: benzingaMar 26th, 2020

AstraZeneca reports Lokelma approved in Japan for treatment of hyperkalaemia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 26th, 2020

How much competition would Fannie Mae really face?

One of the concerns some have raised about Fannie Mae and Freddie Mac .....»»

Category: blogSource: valuewalkMar 24th, 2020

NewsWatch: Trump makes the case for chloroquine as a COVID-19 treatment, though it has not been approved by the FDA for this illness

President Donald Trump and the Food and Drug Administration commissioner appeared to exchange conflicting statements about how a decades-old antimalaria drug is being used to treat COVID-19......»»

Category: topSource: marketwatchMar 19th, 2020

Trump makes the case for chloroquine as a COVID-19 treatment, though it has not been approved by the FDA for this illness

President Donald Trump and the Food and Drug Administration commissioner appeared to exchange conflicting statements about how a decades-old antimalaria drug is being used to treat COVID-19......»»

Category: topSource: marketwatchMar 19th, 2020

A malaria pill from the 1940s has caught the eyes of doctors, analysts, and even Elon Musk as a potential coronavirus treatment

Crystal Cox/Business Insider As the coronavirus pandemic rages on, some drugs are showing promise in treating patients with COVID-19, the disease caused by the novel coronavirus. There are no approved treatments or vac.....»»

Category: topSource: businessinsiderMar 19th, 2020

Analyst Says Gilead"s Remdesivir Could Be Approved "Within Months" For COVID-19 Treatment

A senior research analyst at Piper Sandler believes Gilead Sciences Inc.'s (NASDAQ: GILD) Remdesivir antiviral may soon be approved for COVID-19 treatm.....»»

Category: blogSource: benzingaMar 19th, 2020

Varian Medical says Halcyon 2.0 treatment system approved by China NMPA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 16th, 2020

Banks at risk of losing billions of dollars in fee-based revenues: study

Major banks are at risk of losing billions of dollars of fee-based retail revenue as they face increased regulatory pressure and growing competition from new entrants offering no-fee services, Accenture Plc said on Wednesday......»»

Category: topSource: reutersMar 11th, 2020